Navigation Links
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Date:6/11/2008

Patients Receiving Every Four-Week Subcutaneous Golimumab Also Experienced

Improvements in Physical Function and Disease Activity

PARIS, June 11 /PRNewswire/ -- Findings from two new Phase 3 studies showed that patients receiving every four-week subcutaneous injections of golimumab (CNTO 148) 50 mg and 100 mg and weekly methotrexate (MTX) experienced significant improvements in the signs and symptoms of rheumatoid arthritis (RA) as well as in physical function and disease activity, with some patients achieving remission as measured by Disease Activity Score (DAS28). Findings from two multicenter, randomized, double-blind, placebo-controlled Phase 3 studies showed the efficacy of golimumab in two important populations - MTX-naive patients and patients with active RA despite ongoing treatment with MTX. These data were presented at the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology. Golimumab is currently in the most comprehensive initial Phase 3 development program to date for an anti-tumor necrosis factor (TNF)-alpha biologic therapy with ongoing studies for the treatment of RA, psoriatic arthritis and ankylosing spondylitis.

In the study, GOlimumab FOR subjects With Active RA Despite MTX (GO-FORWARD), both the 50 mg and 100 mg doses of golimumab were studied in patients whose disease was active despite ongoing treatment with MTX. At week 14, 55 percent of patients receiving golimumab 50 mg plus MTX and 56 percent receiving golimumab 100 mg plus MTX achieved at least 20 percent improvement in signs and symptoms of RA (ACR 20), compared to 33 percent of patients receiving placebo and MTX (p<0.01 and p<0.001, respectively). Improvements were seen as early as first clinical assessment, which was four weeks after the first golimumab injection, and generally continued to improve over time.

"The data in this study demonstrate that golimumab is beneficial in improving numerous disease parameters, including in
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... THOUSAND OAKS, Calif. , Jan. 22, 2015  Amgen (NASDAQ: ... quarter and full year 2014 financial results on Tuesday, Jan. 27, ... will be followed by a conference call with the investment community ... be Robert A. Bradway , chairman and chief executive officer, ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015  Profil Institute for ... on diabetes and obesity, announced today a new textbook,  ... Development,  published by Springer, a leading global scientific publisher. ... analyze and illustrate techniques for use in early phase ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
Breaking Medicine Technology:Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... B. Snow Jr., chairman and chief executive officer, Medco Health ... address the Citi 2011 Global Health Care Conference in New ... The presentation at the Hilton, New York, will ... financial officer, is also scheduled to attend. The ...
... VPHM ) today announced that Vincent Milano, president ... Citi 2011 Global Healthcare Conference at 2:00 P.M. ET on ... the Hilton New York Hotel in New York City. ... ViroPharma, will present at the Cowen & Company 31st Annual ...
Cached Medicine Technology:Medco to Present at the Citi 2011 Global Health Care Conference 2ViroPharma to Participate in Two March Healthcare Conferences 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses and ... collection of wedding dresses , and launches a site-wide women’s ... dress on your big day; the wedding gown is the ... to find the most suitable wedding dress. Now, we are ...
(Date:1/22/2015)... 22, 2015 Lower-Auto-Insurance.com has released a new blog ... a car for reducing the costs of an auto insurance ... be able to get lower prices for their vehicle insurance policies. ... role in determining policy costs. Because of this, drivers should ...
(Date:1/22/2015)... NORCROSS, Ga., USA (PRWEB) January 22, 2015 ... implementing a statewide data management system with support from ... Germany. , The new solution will leverage Hexagon Geospatial’s ... raster and vector data as well as point clouds ...
(Date:12/26/2014)... It is said that nothing makes a lady feel more ... dress supplier, shows its new selection of navy cocktail ... , UWDress.com’s navy cocktail gowns are the cornerstones of the ... styles. Simple dresses in bright neon colors can be dressed ...
Breaking Medicine News(10 mins):Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... and 165,000 CABG procedures will be performed, according ... According to two new Millennium Research Group (MRG) ... technology will shift the balance between percutaneous coronary ... procedures for unique subgroups with coronary artery disease ...
... Hearing Loss PreventionPISCATAWAY, N.J., May 14 Siemens Hearing ... Health Week, a weeklong observance from May 10 - ... and Human Services, Office on Women,s Health ... nationwide initiative that encourages women to take steps to ...
... Technologies, Inc. (Nasdaq: PMTI ), a leading ... announced today that Palomar won two patent opposition cases ... and 13, 2009. The opposition hearings concerned European ... respectively, which correspond to U.S. Patent Nos. 5,595,568 and ...
... Offer Tips, Information for Consumers KANSAS CITY, Mo., May ... unemployment rate at 8.5 percent,(1) families are living on ... health insurance coverage. Despite these challenges, there are still ... insurance costs, according to the National Association of Insurance ...
... Partnership to Provide New Yorkers with Free HIV/AIDS TestingNEW YORK, ... announced that The Duane Reade Charitable Foundation has doubled its ... Premier-level sponsor of AIDS Walk New York (AWNY). AWNY ... other AIDS service organizations in the New York tri-state area. ...
... Your Wallet and WaistlineENGLEWOOD CLIFFS, N.J., May 14 ... the same time? Both a registered dietitian and ... of recipe ideas and tips for an upside to ... )As a general guide, Pat Groziak, a ...
Cached Medicine News:Health News:Clinical Data & Innovation Will Shift PCI and CABG Procedures in Europe 2Health News:Clinical Data & Innovation Will Shift PCI and CABG Procedures in Europe 3Health News:Siemens Hearing Celebrates 10th Annual National Women's Health Week 2Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 2Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 3Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 4Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 2Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 3Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 4Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 5Health News:Duane Reade Announces Premier-Level Sponsorship of AIDS Walk New York 2Health News:Is There a Nutritional Upside to a Down Economy? 2Health News:Is There a Nutritional Upside to a Down Economy? 3Health News:Is There a Nutritional Upside to a Down Economy? 4Health News:Is There a Nutritional Upside to a Down Economy? 5Health News:Is There a Nutritional Upside to a Down Economy? 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: